The overall aim is to determine what role PDGF plays in mammalian development. There is evidence that the PDGF-A gene is expressed in preimplantation mouse embryos while the B chain appears later in development, and in accord, the receptor that responds to the A chain (alpha receptor) appears before the beta receptor. Therefore, this study will focus on the early roles of the A chain and the alpha receptor on the development of the pre- and peri-implantation embryo.
The specific aims are as follows: 1. to select those transgenic animals from those that have already been prepared that express excess amounts of PDGF or that have lower levels than the normal animal, and determine the effects of further inducing the transgene with zinc. Selected females will be induced with zinc in the drinking water during gestation to determine the correlations with developmental abnormalities. 2. To prepare antibodies to PDGFs and alpha and beta receptors for detection and quantitation of these polypeptides in transgenic mouse tissues. In addition, by making antibodies to the sites that are involved in ligand binding, we hope to select antisera that will block ligand binding to test the effect on embryo development in vitro. 3. To make a dominant negative construct for PDGF-R-alpha. A carboxyterminal truncated construct will be introduced in an expression vector to interfere with normal alpha receptor function and hence, determine the biological and developmental consequences of inactivated PDGF-receptors in vitro and in vivo. These studies will determine the roles of PDGF growth factors and their receptors in the processes of early cell division and cell differentiation. These animals will also be useful in studying the later consequences of abnormal PDGF and receptor levels in vascular disease and in tumor progression.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
1R01HD028025-01
Application #
3329653
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Project Start
1991-09-01
Project End
1995-08-31
Budget Start
1991-09-01
Budget End
1992-08-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
009214214
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Wiley, L M; Adamson, E D; Tsark, E C (1995) Epidermal growth factor receptor function in early mammalian development. Bioessays 17:839-46
Huang, R P; Darland, T; Okamura, D et al. (1994) Suppression of v-sis-dependent transformation by the transcription factor, Egr-1. Oncogene 9:1367-77
Huang, R P; Ngo, L; Okamura, D et al. (1994) V-sis induces Egr-1 expression by a pathway mediated by c-Ha-Ras. J Cell Biochem 56:469-79
Brice, E C; Wu, J X; Muraro, R et al. (1993) Modulation of mouse preimplantation development by epidermal growth factor receptor antibodies, antisense RNA, and deoxyoligonucleotides. Dev Genet 14:174-84
Adamson, E D (1993) Activities of growth factors in preimplantation embryos. J Cell Biochem 53:280-7
Wu, J X; Adamson, E D (1993) Inhibition of differentiation in P19 embryonal carcinoma cells by the expression of vectors encoding truncated or antisense EGF receptor. Dev Biol 159:208-22
Joh, T; Darland, T; Samuels, M et al. (1992) Regulation of epidermal growth factor receptor gene expression in murine embryonal carcinoma cells. Cell Growth Differ 3:315-25